S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Why Banks Could See a "Cash Frenzy" on March 11 (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Better Than Oil Stocks (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Better Than Oil Stocks (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Why Banks Could See a "Cash Frenzy" on March 11 (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Better Than Oil Stocks (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Better Than Oil Stocks (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Why Banks Could See a "Cash Frenzy" on March 11 (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Better Than Oil Stocks (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Better Than Oil Stocks (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Why Banks Could See a "Cash Frenzy" on March 11 (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Better Than Oil Stocks (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Better Than Oil Stocks (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
NASDAQ:PTX

Pernix Therapeutics (PTX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.03
$0.21
52-Week Range
N/A
Volume
16,105 shs
Average Volume
3.04 million shs
Market Capitalization
$419,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PTX stock logo

About Pernix Therapeutics Stock (NASDAQ:PTX)

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including pain, neurology, and psychiatry. The company's products comprise Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; Silenor, a non-narcotic, non-scheduled, and non-addictive prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance; and Treximet, a fixed dose combination product indicated for the treatment of acute migraine. Pernix Therapeutics Holdings, Inc. markets and sells its non-core products, including generics through its wholly owned subsidiaries; and markets its non-promoted products through distributors and trade partners. It serves drug wholesalers, specialty pharmacies, retail drug stores, mass merchandisers, and grocery store pharmacies. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.


PTX Stock News Headlines

Prescient Therapeutics Ltd
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE!
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets…FOR FREE!
Pernix Therapeutics Holdings Inc (PTX)
See More Headlines
Receive PTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pernix Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:PTX
CUSIP
71426V10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-77,140,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$146.07 million
Book Value
($14.77) per share

Miscellaneous

Free Float
N/A
Market Cap
$419,000.00
Optionable
Optionable
Beta
1.20
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. John Anthony Sedor (Age 74)
    Chairman & CEO
  • Mr. Kenneth R. Pina Esq. (Age 60)
    Sr. VP, Chief Legal & Compliance Officer and Corp. Sec.
  • Mr. Glenn Whaley (Age 51)
    VP of Fin., Principal Financial & Accounting Officer
  • Mr. Anthony M. Orrico
    VP of Technical & Supply Operations
  • Mr. George P. Jones
    VP of Sales & Marketing














PTX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Pernix Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pernix Therapeutics investors own include PIMCO High Income Fund (PHK), Synergy Pharmaceuticals (SGYP), Investors Bancorp (ISBC), Novavax (NVAX), Gevo (GEVO), Amira Nature Foods (ANFI), Argos Therapeutics (ARGSQ), Catalyst Pharmaceuticals (CPRX), (GBSN) (GBSN) and (FPP) (FPP).

This page (NASDAQ:PTX) was last updated on 2/21/2024 by MarketBeat.com Staff